Counteracting Drug-Induced Obesity Using GLP-1 Agonists

The present invention describes administering a GLP-1 agonist to treat obesity caused by the administration of an obesity-inducing drug.

Saved in:
Bibliographic Details
Main Authors RIMVALL KARIN, BOCK CAMILLA, KNUDSEN SANNE MOELLER
Format Patent
LanguageEnglish
Published 27.06.2013
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:The present invention describes administering a GLP-1 agonist to treat obesity caused by the administration of an obesity-inducing drug.
Bibliography:Application Number: US201313776839